joseph on the YMB has pointed this out as a possibility. Fortunately AE has been working on viral research for nearly 20 years. Unfortunately, as far as we know they have no money to continue the research and the last we heard about work being done was over five years ago. I could be mistaken. I would love to see AE's tech be brought back to life.

If we ever get a dividend, get the SEC to approve the S-1 and subsequently the funding arrives, perhaps we will move the research forward.